Lysergic acid diethylamine for generalized anxiety disorder

2026 · doi:10.31234/osf.io/6shqy_v1
preprint OA: closed
View at publisher

Abstract

Letter in reply to Robison R, Barrow R, Conant C, et al. Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial. JAMA. 2025;doi:10.1001/jama.2025.13481 (unpublished, rejected by the journal)

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00